MedTrace Logo

Metabolomics of Thyroid Hormones

NCT03823859 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 332

Last updated 2022-05-17

No results posted yet for this study

Summary

The aim of this study is to develop a metabolome signature of thyroid hormone status. The metabolome signature could be useful in diagnosis and treatment of thyroid dysfunction diseases, especially in cases where TSH cannot be reliably used.

Conditions

Interventions

DIAGNOSTIC_TEST

Indirect calorimetry

Resting energy expenditure

DIAGNOSTIC_TEST

Dual energy X-ray Absorptiometry (DXA)

Body composition

DIAGNOSTIC_TEST

Blood sampling

fT4, fT3, TSH, HDL, LDL, triglycerides, cholesterol, HbA1c, Glucose Thyroid panel

Sponsors & Collaborators

  • ETH Zurich

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Matthias Betz, PD Dr. med. · Klinik Endokrinologie, Diabetes und Metabolismus

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-12
Primary Completion
2021-07-28
Completion
2021-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03823859 on ClinicalTrials.gov